Search

Search bills, members, committees and pages...

Sign In

UCB, INC.

PreviousNext

54 federal lobbying filings, 2023 to 2026.

UCB, INC. is a client on 54 federal lobbying filings, 2023 to 2026, reporting $2.4M across them. Biopharmaceutical company dealing in severe diseases in immunology and neurology. Based in Georgia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

5 it has hired, by filings.

RegistrantFilingsReported
THE NICKLES GROUP, LLC14$860K
UCB, INC.14—
VENN STRATEGIES14$840K
AKIN GUMP STRAUSS HAUER & FELD7$410K
TODD STRATEGY GROUP5$250K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20268$420K$1.2M
202517$730K$1.6M
202412$460K$1.1M
202317$750K$1.3M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues38
TAXTaxation/Internal Revenue Code35
MMMMedicare/Medicaid27
TRDTrade (domestic/foreign)15
INSInsurance6
PHAPharmacy4
BUDBudget/Appropriations2
TARTariff (miscellaneous tariff bills)1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
S. 864HELP Copays Act7
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.6
H.R. 946ORPHAN Cures Act5
H.R. 2423Unfair Tax Prevention Act4
H.R. 591Defending American Jobs and Investment Act4
H.R. 993Emerging Innovative Border Technologies Act3
H.R. 4993Joe Fiandra Access to Home Infusion Act of 20252
S. 1862ORPHAN Cures Act2
H.R. 1189National Plan for Epilepsy Act1
H.R. 1990American Innovation and R&D Competitiveness Act of 20251
H.R. 4317PBM Reform Act of 20251
H.R. 5509Safe Step Act1
H.R. 6423HELP Copays Act1
H.R. 7148Consolidated Appropriations Act, 20261
S. 2903Safe Step Act1
S. 494National Plan for Epilepsy Act1

Lobbyists

Named on the filings.

LobbyistClientsFilings
BRETT BAKER114
GREG D'ANGELO114
JED PERRY114
MARY SAVARY TAYLOR114
MICHAEL SPIRA114
RACHEL JONES HENSLER114
JONATHAN PYATT18
MELISSA FRANCIS (FORMERLY BONICELLI)17
JOSEPH FAWKNER16
JUSTIN LIVESEY16
DANIEL TODD15
JEFF LUCAS15
PAUL EDATTEL15
BRIAN POMPER14
ZACHARY PAULSEN14
ERIC BERGREN12
KATHERINE COTTON12
NICHOLAS UEHLECKE12
PHYLICIA WU12
SAMUEL GOODSTEIN12
TAYLOR SEXTON12
TED LEHMAN12
ZACH DEATHERAGE12
MOLLY FROMM11

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
UCB, INC.AKIN GUMP STRAUSS HAUER & FELD2026 second_quarter$80KJul 20, 2026
UCB, INC.UCB, INC.2026 second_quarter$710KJul 18, 2026
UCB, INC.VENN STRATEGIES2026 second_quarter$80KJul 17, 2026
UCB, INC.THE NICKLES GROUP, LLC2026 second_quarter$70KJul 16, 2026
UCB, INC.AKIN GUMP STRAUSS HAUER & FELD2026 first_quarter$80KApr 20, 2026
UCB, INC.UCB, INC.2026 first_quarter$520KApr 18, 2026
UCB, INC.THE NICKLES GROUP, LLC2026 first_quarter$70KApr 16, 2026
UCB, INC.VENN STRATEGIES2026 first_quarter$40KApr 15, 2026
UCB, INC.THE NICKLES GROUP, LLC2025 fourth_quarter$60KJan 20, 2026
UCB, INC.VENN STRATEGIES2025 fourth_quarter$80KJan 20, 2026
UCB, INC.AKIN GUMP STRAUSS HAUER & FELD2025 fourth_quarter$80KJan 20, 2026
UCB, INC.UCB, INC.2025 fourth_quarter$350KJan 17, 2026
UCB, INC.UCB, INC.2025 third_quarter$340KOct 20, 2025
UCB, INC.VENN STRATEGIES2025 third_quarter$60KOct 20, 2025
UCB, INC.AKIN GUMP STRAUSS HAUER & FELD2025 third_quarter$80KOct 20, 2025
UCB, INC.THE NICKLES GROUP, LLC2025 third_quarter$60KOct 16, 2025
UCB, INC.AKIN GUMP STRAUSS HAUER & FELD2025 second_quarter$80KJul 21, 2025
UCB, INC.UCB, INC.2025 second_quarter$750KJul 21, 2025
UCB, INC.VENN STRATEGIES2025 second_quarter$60KJul 18, 2025
UCB, INC.THE NICKLES GROUP, LLC2025 second_quarter$60KJul 10, 2025
UCB, INC.AKIN GUMP STRAUSS HAUER & FELD2025 first_quarter$10KApr 21, 2025
UCB, INC.VENN STRATEGIES2025 first_quarter$40KApr 21, 2025
UCB, INC.THE NICKLES GROUP, LLC2025 first_quarter$60KApr 21, 2025
UCB, INC.UCB, INC.2025 first_quarter$200KApr 17, 2025
UCB, INC.AKIN GUMP STRAUSS HAUER & FELD2025 first_quarter—Apr 1, 2025